NASDAQ: FHTX - Foghorn Therapeutics Inc.

छह महीने के लिए लाभप्रदता: -55.73%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Foghorn Therapeutics Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system.

अधिक जानकारी
It develops FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and Loxo Oncology to create novel oncology medicines. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2020-10-23
ISIN US3441741077
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://foghorntx.com
Цена ао 3.81
प्रति दिन मूल्य परिवर्तन: 0% (3.59)
प्रति सप्ताह मूल्य परिवर्तन: +11.84% (3.21)
प्रति माह मूल्य परिवर्तन: -18.96% (4.43)
3 महीने में कीमत में बदलाव: -15.33% (4.24)
छह महीने में कीमत में बदलाव: -55.73% (8.11)
प्रति वर्ष मूल्य परिवर्तन: -40.46% (6.03)
3 वर्षों में मूल्य परिवर्तन: -75.73% (14.79)
वर्ष की शुरुआत से मूल्य परिवर्तन: -28.49% (5.02)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 8.16 1
P/BV -3.61 0
P/E 0 0
EV/EBITDA -2.45 0
कुल: 3.88

क्षमता

नाम अर्थ श्रेणी
ROA, % -34.42 0
ROE, % 127.51 10
कुल: 3.33

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.4542 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 7843.02 10
लाभप्रदता Ebitda, % 109.33 10
लाभप्रदता EPS, % 0.2094 1
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Flagship Pioneering Inc. 12674120 29.78
FMR, LLC 2810009 6.6
Raymond James & Associates, Inc. 2068387 4.86
Euclidean Capital LLC 1573761 3.7
Blackrock Inc. 1305868 3.07
Vanguard Group Inc 1025113 2.41
Artal Group S.A. 720720 1.69
Point72 Asset Management, L.P. 540000 1.27
Alphabet Inc. 500901 1.18
Geode Capital Management, LLC 448350 1.05



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Adrian H. B. Gottschalk President, CEO & Director 784.65k 1976 (49 साल)
Dr. Steven F. Bellon Ph.D. Chief Scientific Officer 572.6k 1965 (60 साल)
Mr. Michael J. LaCascia Chief Legal Officer 565.5k 1965 (60 साल)
Dr. Gerald R. Crabtree M.d. Founder & Member of Scientific Advisory Board N/A
Mr. Saurabh Sewak Ph.D. Vice President of Corporate Development N/A
Mr. Carlos Costa Chief People Officer N/A 1973 (52 वर्ष)
Dr. Alfonso Quintas Cardama M.D. Chief Medical Officer 300.16k 1971 (54 वर्ष)
Ms. Karin Hellsvik VP of Corporate Affairs & Investor Relations N/A
Mr. Kristian Humer M.B.A. Chief Financial Officer N/A 1976 (49 साल)
Dr. Anna Rivkin Ph.D. Chief Business Officer

पता: United States, Cambridge. MA, 500 Technology Square - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://foghorntx.com